| Mr Neal Edward Hodgkin, CRNA | |
|
15747 W 150th St, Olathe, KS 66062-4780 | |
| (913) 764-5075 | |
| (913) 764-2979 |
| Full Name | Mr Neal Edward Hodgkin |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 42 Years |
| Location | 15747 W 150th St, Olathe, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942258421 | NPI | - | NPPES |
| 100251340C | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 100447 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Western Plains Medical Complex | Dodge city, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Colleagues Ks Pa | 3870921984 | 9 |
News Archive
Continuing its efforts to fight for settlements that are fair to consumers and mandate real changes in deceptive marketing, advocacy group truthinadvertising.org (TINA.org) has filed an objection in a proposed class-action settlement involving the brand-name glucosamine supplement, Wellesse®. Sold at retailers nationwide, the supplement is advertised as a joint pain remedy to ease pain and even rebuild cartilage.
Noting some of the successes of U.S. foreign assistance in the area of global health, Christopher Elias, president and CEO of PATH, and Richard Stearns, president of World Vision U.S., write in The Hill's "Congress Blog," "Unfortunately, ... American aid is being threatened with severe cuts, though it makes up less than one percent of the federal budget."
A study published in the Journal for Healthcare Quality reports that many huge malpractice awards can be prevented by targeted interventions by health care provider organizations to reduce patient safety risks, such as reducing diagnosis errors.
The best way to estimate the actual prevalence of COVID-19 in the population is by antibody testing. A new study by scientists at Enable Biosciences and published on the preprint server medRxiv* in May 2020 reports the development of fast and sensitive antibody testing kits designed for at-home use. This could significantly boost the measurement of population prevalence of this infection and help understand whether it confers immunity to reinfection.
Dompé, one of Italy's leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research and development biopharmaceutical company, focused on ocular diseases.
› Verified 3 days ago
| Entity Name | Clinical Colleagues Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992725766 PECOS PAC ID: 8729011333 Enrollment ID: O20080514000425 |
News Archive
Continuing its efforts to fight for settlements that are fair to consumers and mandate real changes in deceptive marketing, advocacy group truthinadvertising.org (TINA.org) has filed an objection in a proposed class-action settlement involving the brand-name glucosamine supplement, Wellesse®. Sold at retailers nationwide, the supplement is advertised as a joint pain remedy to ease pain and even rebuild cartilage.
Noting some of the successes of U.S. foreign assistance in the area of global health, Christopher Elias, president and CEO of PATH, and Richard Stearns, president of World Vision U.S., write in The Hill's "Congress Blog," "Unfortunately, ... American aid is being threatened with severe cuts, though it makes up less than one percent of the federal budget."
A study published in the Journal for Healthcare Quality reports that many huge malpractice awards can be prevented by targeted interventions by health care provider organizations to reduce patient safety risks, such as reducing diagnosis errors.
The best way to estimate the actual prevalence of COVID-19 in the population is by antibody testing. A new study by scientists at Enable Biosciences and published on the preprint server medRxiv* in May 2020 reports the development of fast and sensitive antibody testing kits designed for at-home use. This could significantly boost the measurement of population prevalence of this infection and help understand whether it confers immunity to reinfection.
Dompé, one of Italy's leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research and development biopharmaceutical company, focused on ocular diseases.
› Verified 3 days ago
| Entity Name | Clinical Colleagues Ks Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548813967 PECOS PAC ID: 3870921984 Enrollment ID: O20200323002520 |
News Archive
Continuing its efforts to fight for settlements that are fair to consumers and mandate real changes in deceptive marketing, advocacy group truthinadvertising.org (TINA.org) has filed an objection in a proposed class-action settlement involving the brand-name glucosamine supplement, Wellesse®. Sold at retailers nationwide, the supplement is advertised as a joint pain remedy to ease pain and even rebuild cartilage.
Noting some of the successes of U.S. foreign assistance in the area of global health, Christopher Elias, president and CEO of PATH, and Richard Stearns, president of World Vision U.S., write in The Hill's "Congress Blog," "Unfortunately, ... American aid is being threatened with severe cuts, though it makes up less than one percent of the federal budget."
A study published in the Journal for Healthcare Quality reports that many huge malpractice awards can be prevented by targeted interventions by health care provider organizations to reduce patient safety risks, such as reducing diagnosis errors.
The best way to estimate the actual prevalence of COVID-19 in the population is by antibody testing. A new study by scientists at Enable Biosciences and published on the preprint server medRxiv* in May 2020 reports the development of fast and sensitive antibody testing kits designed for at-home use. This could significantly boost the measurement of population prevalence of this infection and help understand whether it confers immunity to reinfection.
Dompé, one of Italy's leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research and development biopharmaceutical company, focused on ocular diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Neal Edward Hodgkin, CRNA 15747 W 150th St, Olathe, KS 66062-4780 Ph: (913) 764-5075 | Mr Neal Edward Hodgkin, CRNA 15747 W 150th St, Olathe, KS 66062-4780 Ph: (913) 764-5075 |
News Archive
Continuing its efforts to fight for settlements that are fair to consumers and mandate real changes in deceptive marketing, advocacy group truthinadvertising.org (TINA.org) has filed an objection in a proposed class-action settlement involving the brand-name glucosamine supplement, Wellesse®. Sold at retailers nationwide, the supplement is advertised as a joint pain remedy to ease pain and even rebuild cartilage.
Noting some of the successes of U.S. foreign assistance in the area of global health, Christopher Elias, president and CEO of PATH, and Richard Stearns, president of World Vision U.S., write in The Hill's "Congress Blog," "Unfortunately, ... American aid is being threatened with severe cuts, though it makes up less than one percent of the federal budget."
A study published in the Journal for Healthcare Quality reports that many huge malpractice awards can be prevented by targeted interventions by health care provider organizations to reduce patient safety risks, such as reducing diagnosis errors.
The best way to estimate the actual prevalence of COVID-19 in the population is by antibody testing. A new study by scientists at Enable Biosciences and published on the preprint server medRxiv* in May 2020 reports the development of fast and sensitive antibody testing kits designed for at-home use. This could significantly boost the measurement of population prevalence of this infection and help understand whether it confers immunity to reinfection.
Dompé, one of Italy's leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately held Italian research and development biopharmaceutical company, focused on ocular diseases.
› Verified 3 days ago
Mary W Minden, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4340 | |
Deborah Marie Pelch, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, Suite 306, Olathe, KS 66061 Phone: 913-782-2292 Fax: 913-782-2381 | |
Mrs. Cindy J Goe, CRNA MA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 14619 S Lucille St, Olathe, KS 66062 Phone: 913-681-9716 | |
Jan L. Coons, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, Suite 306, Olathe, KS 66061 Phone: 913-785-2292 Fax: 913-782-2381 | |
Dr. Paul Chi Tung, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4208 Fax: 913-782-2381 | |
Ms. Michelle Salazar, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4200 | |
Timothy J Flynn, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 20375 W 151st St, Suite 306, Olathe, KS 66061 Phone: 913-782-2292 Fax: 913-782-2381 |